ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

Audentes Therapeutics: This Gene Therapy Story Could Deliver Significant Upside In 2017 – Seeking Alpha

Seeking AlphaAudentes Therapeutics: This Gene Therapy Story Could Deliver Significant Upside In 2017Seeking AlphaAudentes Therapeutics: This Gene Therapy Story Could Deliver Significant Upside In 2017. Feb. 9.17 | About: Audentes Therapeutics (BOLD) &m… Continue reading

2017-02-09 Michael Zand NEWS

Myelodysplastic Syndrome Mutations Offer Prognostic Hints for Stem Cell Transplant Patients – GenomeWeb

Continue reading

2017-02-09 Michael Zand NEWS

A Different Version Of Passengers Was Pitched To The Studio, And It Sounds Really Cool – Cinema Blend

Cinema BlendA Different Version Of Passengers Was Pitched To The Studio, And It Sounds Really CoolCinema BlendThe film deals with a character, played by Chris Pratt, who is woken from suspended animation 90 years before his spacecraft reaches his new h… Continue reading

2017-02-09 Michael Zand NEWS

Nanoparticle-delivered CRISPR tools could treat hemophilia, cystic fibrosis and muscular dystrophy – Genetic Literacy Project

Genetic Literacy ProjectNanoparticle-delivered CRISPR tools could treat hemophilia, cystic fibrosis and muscular dystrophyGenetic Literacy ProjectMore and more scientists are using the powerful new gene-editing tool known as CRISPR/Cas9, a technology i… Continue reading

2017-02-09 Michael Zand NEWS

For people with congenital hearing loss, gene therapy successful in mice offers promise – Genetic Literacy Project

Myelodysplastic Syndrome Mutations Offer Prognostic Hints for Stem Cell Transplant Patients
GenomeWeb
NEW YORK (GenomeWeb) – Looking at the gene sequences that have gone awry in patients with myelodysplastic syndrome (MDS) can offer clues to the cases most likely to progress to bone marrow failure after allogeneic hematopoietic stem cell transplant …

and more »

Continue reading

2017-02-09 Michael Zand NEWS

Neovia Starts Enrollment in Phase 1 Immunotherapy Trial for Advanced Cancers – Immuno-Oncology News

Immuno-Oncology NewsNeovia Starts Enrollment in Phase 1 Immunotherapy Trial for Advanced CancersImmuno-Oncology NewsThe first-in-human Neovia Oncology Phase 1 trial (NCT02797795) assessing the safety and effectiveness of the investigational drug NEV-… Continue reading

2017-02-09 Michael Zand NEWS

Neovia Starts Enrollment in Phase 1 Immunotherapy Trial for Advanced Cancers – Immuno-Oncology News

Immuno-Oncology NewsNeovia Starts Enrollment in Phase 1 Immunotherapy Trial for Advanced CancersImmuno-Oncology NewsThe first-in-human Neovia Oncology Phase 1 trial (NCT02797795) assessing the safety and effectiveness of the investigational drug NEV-… Continue reading

2017-02-09 Michael Zand NEWS

Genetic profiling can guide stem cell transplantation for patients with myelodysplastic syndrome – Medical Xpress


Genetic Literacy Project

For people with congenital hearing loss, gene therapy successful in mice offers promise
Genetic Literacy Project
An improved gene therapy vector restores hearing and balance in genetically deaf mice, according to Boston’s Children’s Hospital researchers…[T]he mice’s levels of hearing are reported to be able to detect sounds as soft as 25 decibels, which is …
Benign virus allows deaf mice to hear: StudyGeo News, Pakistan

all 2 news articles »

Continue reading

2017-02-09 Michael Zand NEWS
  • 1
  • …
  • 2,120
  • 2,121
  • 2,122
  • 2,123
  • 2,124
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

Medical Xpress

Genetic profiling can guide stem cell transplantation for patients with myelodysplastic syndrome
Medical Xpress
A single blood test and basic information about a patient’s medical status can indicate which patients with myelodysplastic syndrome (MDS) are likely to benefit from a stem cell transplant, and the intensity of pre-transplant chemotherapy and/or …

and more »